Does Chicory Root Fiber Satiety Randomized Trial work?

Updated August 2026

Quick Answer

Chicory Root Fiber Satiety Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Background Gastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden.

Key Takeaways

  • 01Background Gastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden. [Teterovska R (2025)]
  • 02Discrepancies between product information and available scientific evidence highlight regulatory and consumer protection challenges. [Teterovska R (2025)]
  • 03Conventional therapies may have limited efficacy or undesirable side effects, underscoring the need for safe complementary approaches. [Teterovska R (2025)]
  • 04Interestingly, we previously found that short-term (3 weeks), daily intake of 30 g/day of dried chicory root fibers in individuals at risk of T2D rapidly modulated the gut microbiota by increasing relative levels ofspp. [Omary Lina (2025)]
The current Migaku evidence database contains 2 reusable source documents for Chicory Root Fiber Satiety Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Background Gastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden. [Teterovska R (2025); evidence level 4] - Discrepancies between product information and available scientific evidence highlight regulatory and consumer protection challenges. [Teterovska R (2025); evidence level 4] - Conventional therapies may have limited efficacy or undesirable side effects, underscoring the need for safe complementary approaches. [Teterovska R (2025); evidence level 4] - Interestingly, we previously found that short-term (3 weeks), daily intake of 30 g/day of dried chicory root fibers in individuals at risk of T2D rapidly modulated the gut microbiota by increasing relative levels ofspp. [Omary Lina (2025); evidence level 4] - Interestingly, we show a pivotal role of the intrinsic chicory root fibers in modulating microbial butyrate production pathways and fecal SCFA concentrations, as well as whole-body insulin sensitivity, insulin-mediated non-oxidative glucose disposal, fasting circulating glucose, and triglyceride (TG) concentrations with trends toward an increased peripheral insulin sensitivity and reduced liver fat accumulation. [Omary Lina (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation.
  2. Intrinsic chicory root fibers modulate colonic microbial butyrate-producing pathways and improve insulin sensitivity in individuals with obesity